| 000 | 01067 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516113656.0 | ||
| 264 | 0 | _c20130110 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a0171-2004 | ||
| 024 | 7 |
_a10.1007/978-3-642-25758-2_2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKeefe, Richard S E | |
| 245 | 0 | 0 |
_aCognitive impairment in schizophrenia. _h[electronic resource] |
| 260 |
_bHandbook of experimental pharmacology _c2012 |
||
| 300 |
_a11-37 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aAttention |
| 650 | 0 | 4 |
_aCognition Disorders _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLearning |
| 650 | 0 | 4 | _aMemory |
| 650 | 0 | 4 | _aNeuropsychological Tests |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aSchizophrenic Psychology |
| 700 | 1 | _aHarvey, Philip D | |
| 773 | 0 |
_tHandbook of experimental pharmacology _gno. 213 _gp. 11-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-642-25758-2_2 _zAvailable from publisher's website |
| 999 |
_c22149950 _d22149950 |
||